Pharmaceuticals

Phenobarbital Industry Insights: Market Forecast to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Phenobarbital Market Expected To Become By 2029 Compared With Its 2025 Level?

The phenobarbital market has experienced consistent expansion in recent times. Projections indicate it will expand from $1.47 billion in 2024 to $1.54 billion in 2025, showing a compound annual growth rate (CAGR) of 4.4%. Historically, this expansion has been driven by its extensive application in epilepsy treatment, the common occurrence of epilepsy and seizure conditions, state-sponsored supply initiatives, increasing requirements in animal medicine, and drives towards comprehensive healthcare access.

The phenobarbital market is anticipated to show consistent expansion in the coming years. It is projected to achieve a size of $1.87 billion by 2029, with a compound annual growth rate (CAGR) of 4.9%. This growth throughout the forecast period can be attributed to factors such as the increasing production of generic drugs, a greater focus on managing neurological diseases, the expansion of digital supply chains and e-pharmacy platforms, regulatory changes that support the use of generics, and stable regulatory pathways for generic medications. Prominent trends for the forecast period include the development of easier-to-administer delivery methods, ongoing innovation in research and development, the creation of extended-release formulations, enhancements in drug delivery systems, and investments aimed at improving production techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24377&type=smp

What Are The Drivers Pushing New Developments In The Phenobarbital Market?

The increasing prevalence of epilepsy is projected to bolster the growth of the phenobarbital market in the foreseeable future. This neurological disorder is characterized by recurring, unprovoked seizures that arise from atypical electrical activity within the brain. The rise in epilepsy’s prevalence can be attributed to improved awareness, as more individuals recognize symptoms and seek medical diagnoses, resulting in a greater number of reported cases. Phenobarbital proves beneficial for epilepsy treatment as an anticonvulsant medication that operates by moderating the activity of the brain’s neurons, thereby assisting in the prevention and control of seizures. For instance, in May 2024, a report published by the Centers for Disease Control and Prevention, a US-based government agency, revealed that between 2021 and 2022, approximately 2.9 million adults in the U.S. were living with active epilepsy, which constituted about 1% of the adult population. Thus, the rising incidence of epilepsy is anticipated to propel the phenobarbital market’s expansion.

How Is The Phenobarbital Market Segmented?

The phenobarbital market covered in this report is segmented –

1) By Indication: Epilepsy, Neonatal Seizures

2) By Dosage Forms: Tablets, Capsules, Injectables

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Application: Seizure Management, Anesthesia, Sleep Disorders, Alcohol Withdrawal Syndrome

5) By End User: Hospitals, Clinics, Research Laboratories, Homecare Settings

Subsegments:

1) By Epilepsy: Focal (Partial) Seizures, Generalized Tonic-Clonic Seizures, Status Epilepticus, Refractory Epilepsy, Idiopathic Epilepsy

2) By Neonatal Seizures: Hypoxic-Ischemic Encephalopathy (HIE)-Induced Seizures, Intracranial Hemorrhage-Induced Seizures, Metabolic Disorders, Congenital Brain Malformations, Infections

What Key Innovation Trends Are Fueling Advancements In The Phenobarbital Market?

Leading companies in the phenobarbital market are concentrating on developing innovative solutions, such as phenobarbital sodium, to enhance treatment effectiveness and safety. Phenobarbital sodium is the sodium salt form of phenobarbital, a medication primarily used as an anticonvulsant and sedative. It is commonly prescribed to manage seizures, particularly in conditions like epilepsy, as well as to treat anxiety and insomnia, and sometimes to induce sedation before medical procedures. For instance, in January 2023, Sun Pharmaceutical Industries Ltd., an India-based pharmaceutical company, launched SEZABY (phenobarbital sodium) in the U.S., making it the first and only FDA-approved medication specifically indicated for treating seizures in both term and preterm neonates. This new formulation is free of benzyl alcohol and propylene glycol, making it safer for use in newborns. SEZABY received orphan drug designation and is supported by clinical data demonstrating its effectiveness in controlling neonatal seizures, thereby addressing a critical unmet need in this vulnerable patient population.

Which Leading Companies Dominate The Phenobarbital Market Share?

Major companies operating in the phenobarbital market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, H. Lundbeck A/S, Sandoz Group AG, Yashiro Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Par Pharmaceutical Inc., Shandong Xinhua Pharmaceutical Co. Ltd., Manus Aktteva Biopharma LLP, JPN Pharma Pvt. Ltd., Alkaloida Chemical Company Zrt., Harman Finochem Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/phenobarbital-global-market-report

Which Region Is Projected To Lead The Phenobarbital Market During The Forecast Period?

North America was the largest region in the phenobarbital market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phenobarbital market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Phenobarbital Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24377&type=smp

Browse Through More Reports Similar to the Global Phenobarbital Market 2025, By The Business Research Company

Anti Viral Drug Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Artificial Intelligence Ai In Drug Discovery Market 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-drug-discovery-market

Artificial Intelligence In Drug Discovery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795